ENDOVASC LTD INC
10KSB, EX-27, 2000-09-29
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: ENDOVASC LTD INC, 10KSB, 2000-09-29
Next: ENDOVASC LTD INC, NT 10-K, 2000-09-29



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>

                                      EX-27

                             Financial Data Schedule
                               Endovasc Ltd, Inc.


</LEGEND>

<S>                                                           <C>
<PERIOD-TYPE>                                                  12-MOS
<FISCAL-YEAR-END>                                              jun-30-1999
<PERIOD-END>                                                   jun-30-2000
<CASH>                                                         0
<SECURITIES>                                                   0
<RECEIVABLES>                                                  0
<ALLOWANCES>                                                   0
<INVENTORY>                                                    0
<CURRENT-ASSETS>                                               926,121
<PP&E>                                                         43,244
<DEPRECIATION>                                                 14,507
<TOTAL-ASSETS>                                                 1,129,636
<CURRENT-LIABILITIES>                                          1,063,684
<BONDS>                                                        0
                                          0
                                                    15
<COMMON>                                                       14,553
<OTHER-SE>                                                     25,526
<TOTAL-LIABILITY-AND-EQUITY>                                   1,129,636
<SALES>                                                        24,312
<TOTAL-REVENUES>                                               24,312
<CGS>                                                          0
<TOTAL-COSTS>                                                  2,879,039
<OTHER-EXPENSES>                                               0
<LOSS-PROVISION>                                               0
<INTEREST-EXPENSE>                                             127,197
<INCOME-PRETAX>                                                (2,847,952)
<INCOME-TAX>                                                   0
<INCOME-CONTINUING>                                            (2,847,952)
<DISCONTINUED>                                                 0
<EXTRAORDINARY>                                                127,375
<CHANGES>                                                      0
<NET-INCOME>                                                   (2,847,952)
<EPS-BASIC>                                                    (0.31)
<EPS-DILUTED>                                                  (0.31)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission